A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
Recruiting · NCT07520565 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. | androgen insensitivity syndrome, non-human animal | Recruiting | Phase 3 | 2026-04-09 | NCT07520565 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biocells (Beijing) Biotech Co.,Ltd | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital , Capital Medical University | Beijing | China | 1 |
| Daqing Oilfield General Hospital | Daqing | China | 3 |
| Harrison International Peace Hospital | Hengshui | China | 1 |
| Linfen Central Hospital | Linfen | China | 10 |
| Linyi People's Hospital | Linyi | China | 18 |
| MeiHekou Central Hospital | Meihekou | China | 1 |
| The Affiliated Hospital of Shenyang Medical College | Shenyang | China | 1 |
| The First Affiliated Hospital of Nanyang Medicinal College | Nanyang | China | 1 |
| Xianyang Hospital of Yan'an University | Xianyang | China | 2 |